ALL CURENCY METRICS ARE IN BRAZIL REAIS (R$)
SÃO PAULO, Feb. 15, 2023 /PRNewswire/ -- Telefônica Brasil - ((B3: VIVT3, NYSE:VIV), announces its results for 4Q22 and 2022.
Vivo reinforces
Israeli-based next-gen psychedelics biotech Clearmind Medicine (NASDAQ: CMND) together with partner clinical-stage pharma company SciSparc (NASDAQ: SPRC) has filed three provisional patent applications with the United S
The company expects Q1 adjusted EBITDA margins the lowest for the year at approximately 10% and then improve sequentially throughout the year, returning to more normalized levels in Q4. Sees 2H adjusted EBITDA margins
Credo Technology Group Holding Ltd's (NASDAQ: CRDO) largest customer has reduced its demand forecast for certain Credo products for reasons Credo understands are unrelated to Credo's performance.